{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:03:10Z","timestamp":1793329390355,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"ADIRAL"},{"DOI":"10.13039\/100016819","name":"Octapharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00134-026-08338-0","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:35:53Z","timestamp":1772015753000},"page":"456-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plasminogen supplementation reverses fibrinolytic insufficiency in sepsis-induced disseminated intravascular coagulation: a pilot study"],"prefix":"10.1007","volume":"52","author":[{"given":"Marine","family":"Tschirhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Curtiaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Abou Rjeily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Merdji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Demiselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Severac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micael","family":"Ca\u00e7ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiha","family":"El Ghazouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Angles-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Toti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-6800","authenticated-orcid":false,"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"8338_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"8338_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13613-017-0339-5","volume":"7","author":"X Delabranche","year":"2017","unstructured":"Delabranche X, Helms J, Meziani F (2017) Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care 7:117","journal-title":"Ann Intensive Care"},{"key":"8338_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","volume":"49","author":"J Helms","year":"2023","unstructured":"Helms J, Iba T, Connors JM, Gando S, Levi M, Meziani F, Levy JH (2023) How to manage coagulopathies in critically ill patients. Intensive Care Med 49:273\u2013290","journal-title":"Intensive Care Med"},{"key":"8338_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13613-025-01434-2","volume":"15","author":"A Curtiaud","year":"2025","unstructured":"Curtiaud A, Iba T, Angles-Cano E, Meziani F, Helms J (2025) Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications. Ann Intensive Care 15:12","journal-title":"Ann Intensive Care"},{"key":"8338_CR5","doi-asserted-by":"publisher","first-page":"14270","DOI":"10.1096\/fj.201901363RRR","volume":"33","author":"D Barbosa da Cruz","year":"2019","unstructured":"Barbosa da Cruz D, Helms J, Aquino LR, Stiel L, Cougourdan L, Broussard C, Chafey P, Ries-Kautt M, Meziani F, Toti F, Gaussem P, Angles-Cano E (2019) DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma. FASEB J 33:14270\u201314280","journal-title":"FASEB J"},{"key":"8338_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08280-7","author":"J Helms","year":"2026","unstructured":"Helms J, Angles-Cano E, Meziani F (2026) Low plasminogen and impaired fibrinolysis in sepsis-induced DIC: a potential mechanistic link and therapeutic perspective. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-025-08280-7","journal-title":"Intensive Care Med"},{"issue":"Pt 3","key":"8338_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1042\/bj3090977","volume":"309","author":"S Namiranian","year":"1995","unstructured":"Namiranian S, Naito Y, Kakkar VV, Scully MF (1995) Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase. Biochem J 309(Pt 3):977\u2013982","journal-title":"Biochem J"},{"key":"8338_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/SHK.0000000000000719","volume":"47","author":"X Delabranche","year":"2017","unstructured":"Delabranche X, Stiel L, Severac F, Galoisy AC, Mauvieux L, Zobairi F, Lavigne T, Toti F, Angl\u00e8s-Cano E, Meziani F, Boisram\u00e9-Helms J (2017) Evidence of netosis in septic shock-induced disseminated intravascular coagulation. Shock 47:313\u2013317","journal-title":"Shock"},{"key":"8338_CR9","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1097\/CCM.0000000000001851","volume":"44","author":"L Stiel","year":"2016","unstructured":"Stiel L, Delabranche X, Galoisy AC, Severac F, Toti F, Mauvieux L, Meziani F, Boisrame-Helms J (2016) Neutrophil fluorescence: a new indicator of cell activation during septic shock-induced disseminated intravascular coagulation. Crit Care Med 44:e1132\u2013e1136","journal-title":"Crit Care Med"},{"key":"8338_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/SHK.0000000000000980","volume":"49","author":"L Stiel","year":"2018","unstructured":"Stiel L, Meziani F, Helms J (2018) Neutrophil activation during septic shock. Shock 49:371\u2013384","journal-title":"Shock"},{"key":"8338_CR11","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.aam8897","volume":"358","author":"M Jimenez-Alcazar","year":"2017","unstructured":"Jimenez-Alcazar M, Rangaswamy C, Panda R, Bitterling J, Simsek YJ, Long AT, Bilyy R, Krenn V, Renne C, Renne T, Kluge S, Panzer U, Mizuta R, Mannherz HG, Kitamura D, Herrmann M, Napirei M, Fuchs TA (2017) Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science 358:1202\u20131206","journal-title":"Science"},{"key":"8338_CR12","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1182\/blood-2017-09-806729","volume":"131","author":"AD Shapiro","year":"2018","unstructured":"Shapiro AD, Nakar C, Parker JM, Albert GR, Moran JE, Thibaudeau K, Thukral N, Hardesty BM, Laurin P, Sandset PM (2018) Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency. Blood 131:1301\u20131310","journal-title":"Blood"},{"key":"8338_CR13","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1097\/PCC.0000000000002578","volume":"22","author":"AA El-Nawawy","year":"2021","unstructured":"El-Nawawy AA, Elshinawy MI, Khater DM, Moustafa AA, Hassanein NM, Wali YA, Nazir HF (2021) Outcome of early hemostatic intervention in children with sepsis and nonovert disseminated intravascular coagulation admitted to PICU: a randomized controlled trial. Pediatr Crit Care Med 22:e168\u2013e177","journal-title":"Pediatr Crit Care Med"},{"key":"8338_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13054-020-2799-5","volume":"24","author":"K Stahl","year":"2020","unstructured":"Stahl K, Schmidt JJ, Seeliger B, Schmidt BMW, Welte T, Haller H, Hoeper MM, Budde U, Bode C, David S (2020) Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock. Crit Care 24:71","journal-title":"Crit Care"},{"key":"8338_CR15","doi-asserted-by":"publisher","first-page":"107602962110533","DOI":"10.1177\/10760296211053313","volume":"27","author":"J Weng","year":"2021","unstructured":"Weng J, Chen M, Fang D, Liu D, Guo R, Yang S (2021) Therapeutic plasma exchange protects patients with sepsis-associated disseminated intravascular coagulation by improving endothelial function. Clin Appl Thromb Hemost 27:10760296211053312","journal-title":"Clin Appl Thromb Hemost"},{"key":"8338_CR16","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, Pettila V, Wittebole X, Meziani F, Mercier E, Lobo SM, Barie PS, Crowther M, Esmon CT, Fareed J, Gando S, Gorelick KJ, Levi M, Mira JP, Opal SM, Parrillo J, Russell JA, Saito H, Tsuruta K, Sakai T, Fineberg D, Group ST (2019) Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA 321:1993\u20132002","journal-title":"JAMA"},{"key":"8338_CR17","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1161\/hq0901.094496","volume":"21","author":"H Weiler","year":"2001","unstructured":"Weiler H, Lindner V, Kerlin B, Isermann BH, Hendrickson SB, Cooley BC, Meh DA, Mosesson MW, Shworak NW, Post MJ, Conway EM, Ulfman LH, von Andrian UH, Weitz JI (2001) Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol 21:1531\u20131537","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"8338_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2008.214","volume":"4","author":"D Rittirsch","year":"2009","unstructured":"Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4:31\u201336","journal-title":"Nat Protoc"},{"key":"8338_CR19","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.1021\/bi00244a035","volume":"30","author":"V Fleury","year":"1991","unstructured":"Fleury V, Angles-Cano E (1991) Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry 30:7630\u20137638","journal-title":"Biochemistry"},{"key":"8338_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0003-2697(86)90082-5","volume":"153","author":"E Angles-Cano","year":"1986","unstructured":"Angles-Cano E (1986) A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators. Anal Biochem 153:201\u2013210","journal-title":"Anal Biochem"},{"key":"8338_CR21","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.1021\/bi00244a035","volume":"30","author":"V Fleury","year":"1991","unstructured":"Fleury V, Anglescano E (1991) characterization of the binding of plasminogen to fibrin surfaces\u2014the role of carboxy-terminal lysines. Biochemistry 30:7630\u20137638","journal-title":"Biochemistry"},{"key":"8338_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1432-1033.1993.tb18173.x","volume":"216","author":"V Fleury","year":"1993","unstructured":"Fleury V, Loyau S, Lijnen HR, Nieuwenhuizen W, Angles-Cano E (1993) Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface. Eur J Biochem 216:549\u2013556","journal-title":"Eur J Biochem"},{"key":"8338_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-2141.1984.tb02179.x","volume":"56","author":"NA Booth","year":"1984","unstructured":"Booth NA, Bennett B (1984) Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis. Br J Haematol 56:545\u2013556","journal-title":"Br J Haematol"},{"key":"8338_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","volume":"129","author":"G Cesarman-Maus","year":"2005","unstructured":"Cesarman-Maus G, Hajjar KA (2005) Molecular mechanisms of fibrinolysis. Br J Haematol 129:307\u2013321","journal-title":"Br J Haematol"},{"key":"8338_CR25","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","volume":"113","author":"SS Adam","year":"2009","unstructured":"Adam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Blood 113:2878\u20132887","journal-title":"Blood"},{"key":"8338_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tim.2011.01.001","volume":"19","author":"L Dejager","year":"2011","unstructured":"Dejager L, Pinheiro I, Dejonckheere E, Libert C (2011) Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol 19:198\u2013208","journal-title":"Trends Microbiol"},{"key":"8338_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.thromres.2010.12.002","volume":"128","author":"LO Berthelsen","year":"2011","unstructured":"Berthelsen LO, Kristensen AT, Tranholm M (2011) Animal models of DIC and their relevance to human DIC: a systematic review. Thromb Res 128:103\u2013116","journal-title":"Thromb Res"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08338-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08338-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08338-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:34:11Z","timestamp":1774877651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08338-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["8338"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08338-0","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JH has received honoraria for lectures from Asahi Kasei, Pfizer PFE France, Sanofi Aventis France, Inotrem, MSD, Octapharma, and Shionogi, and serves on the Steering Committees for Bayer and AngioDynamics. The other authors have no conflict of interest to declare. JH is a Section Editor for Intensive Care Medicine. She has not taken part in the review or selection process of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study received approval from the Comit\u00e9 de Protection des Personnes (CPP) Sud-Est I on March 14, 2020, and authorization from the Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9 (ANSM) on February 18, 2020. All amendments to the protocol were reviewed and approved by both authorities. The study was registered on ClinicalTrials.gov under the identifier NCT04580563. All experimental protocols (mice model) were approved by the French Ministry of Higher Education and Research and the local Ethics Committee of Strasbourg, \u201c\n                      Comit\u00e9 R\u00e9gional d\u2019\u00c9thique en Mati\u00e8re d\u2019Exp\u00e9rimentation Animale de Strasbourg\n                      \u201d (CREMEAS), under agreement number APAFIS#38203\u20132022081015287584 v4.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}